Rationale, design and objectives of ARegPKD, a European ARPKD registry study (Q35176977)

6 August 2017

title

Rationale, design and objectives of ARegPKD, a European ARPKD registry study (English)

1 reference

6 August 2017

12

Thomas Illig

0 references

Max Christoph Liebau

Max Christoph Liebau

27

0 references

Mieczyslaw Litwin

Mieczyslaw Litwin

16

0 references

Norman Klopp

14

Norman Klopp

1 reference

6 August 2017

22

Dorota Wicher

1 reference

6 August 2017

Augustina Jankauskiene

13

Augustina Jankauskiene

1 reference

6 August 2017

Kathrin Ebner

1

1 reference

6 August 2017

Markus Feldkoetter

2

1 reference

6 August 2017

Gema Ariceta

3

1 reference

6 August 2017

Carsten Bergmann

4

1 reference

6 August 2017

Reinhard Buettner

5

1 reference

6 August 2017

Anke Doyon

6

1 reference

6 August 2017

Ali Duzova

7

1 reference

6 August 2017

Heike Goebel

8

1 reference

6 August 2017

Dieter Haffner

9

1 reference

6 August 2017

Barbara Hero

10

1 reference

6 August 2017

Bernd Hoppe

11

1 reference

6 August 2017

Jens König

15

1 reference

6 August 2017

Djalila Mekahli

17

1 reference

6 August 2017

Bruno Ranchin

18

1 reference

6 August 2017

Anja Sander

19

1 reference

6 August 2017

Sara Testa

20

1 reference

6 August 2017

Lutz Thorsten Weber

21

1 reference

6 August 2017

Ayse Yuzbasioglu

23

1 reference

6 August 2017

Klaus Zerres

24

1 reference

6 August 2017

Jörg Dötsch

25

1 reference

6 August 2017

Franz Schaefer

26

1 reference

6 August 2017

ESCAPE Study Group

28

1 reference

6 August 2017

GPN Study Group

29

1 reference

6 August 2017

publication date

18 February 2015

1 reference

6 August 2017

1 reference

6 August 2017

volume

16

1 reference

6 August 2017

page(s)

22

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

copyright license

start time

18 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s12882-015-0002-z

0 references

cites work

Blood pressure in early autosomal dominant polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Angiotensin blockade in late autosomal dominant polycystic kidney disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

An emerging molecular understanding and novel targeted treatment approaches in pediatric kidney diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Modeling human disease in humans: the ciliopathies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

When cilia go bad: cilia defects and ciliopathies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Everolimus in patients with autosomal dominant polycystic kidney disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Strict blood-pressure control and progression of renal failure in children

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft für Pädiatrische, Nephrologie

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359504

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD)

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS12882-015-0002-Z

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25886171

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical treatment of polycystic kidney disease (APKD): do we need further suggestions from rodents?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25886171

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25886171

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12882-015-0002-Z

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference